Andrii Monastyrskyi, Dennis E Kyle, Roman Manetsch1. 1. Department of Chemistry, University of South Florida, CHE 205, 4202 E. Fowler Ave., Tampa, Florida 33620, USA. manetsch@usf.edu.
Abstract
Infectious diseases are the second leading cause of deaths in the world with malaria being responsible for approximately the same amount of deaths as cancer in 2012. Despite the success in malaria prevention and control measures decreasing the disease mortality rate by 45% since 2000, the development of single-dose therapeutics with radical cure potential is required to completely eradicate this deadly condition. Targeting multiple stages of the malaria parasite is becoming a primary requirement for new candidates in antimalarial drug discovery and development. Recently, 4(1H)- pyridone, 4(1H)-quinolone, 1,2,3,4-tetrahydroacridone, and phenoxyethoxy-4(1H)-quinolone chemotypes have been shown to be antimalarials with blood stage activity, liver stage activity, and transmission blocking activity. Advancements in structure-activity relationship and structure-property relationship studies, biological evaluation in vitro and in vivo, as well as pharmacokinetics of the 4(1H)-pyridone and 4(1H)-quinolone chemotypes are discussed.
Infectious diseases are the second leading cause of deaths in the world with n class="Disease">malaria being responsible for approximately the same amount of deaths as cancer in 2012. Despite the success in malaria prevention and control measures decreasing the disease mortality rate by 45% since 2000, the development of single-dose therapeutics with radical cure potential is required to completely eradicate this deadly condition. Targeting multiple stages of the malaria parasite is becoming a primary requirement for new candidates in antimalarial drug discovery and development. Recently, 4(1H)- pyridone, 4(1H)-quinolone, 1,2,3,4-tetrahydroacridone, and phenoxyethoxy-4(1H)-quinolone chemotypes have been shown to be antimalarials with blood stage activity, liver stage activity, and transmission blocking activity. Advancements in structure-activity relationship and structure-property relationship studies, biological evaluation in vitro and in vivo, as well as pharmacokinetics of the 4(1H)-pyridone and 4(1H)-quinolone chemotypes are discussed.
Authors: José M Bueno; Esperanza Herreros; Iñigo Angulo-Barturen; Santiago Ferrer; José M Fiandor; Francisco J Gamo; Domingo Gargallo-Viola; Geo Derimanov Journal: Future Med Chem Date: 2012-12 Impact factor: 3.808
Authors: Olivo Miotto; Jacob Almagro-Garcia; Magnus Manske; Bronwyn Macinnis; Susana Campino; Kirk A Rockett; Chanaki Amaratunga; Pharath Lim; Seila Suon; Sokunthea Sreng; Jennifer M Anderson; Socheat Duong; Chea Nguon; Char Meng Chuor; David Saunders; Youry Se; Chantap Lon; Mark M Fukuda; Lucas Amenga-Etego; Abraham V O Hodgson; Victor Asoala; Mallika Imwong; Shannon Takala-Harrison; François Nosten; Xin-Zhuan Su; Pascal Ringwald; Frédéric Ariey; Christiane Dolecek; Tran Tinh Hien; Maciej F Boni; Cao Quang Thai; Alfred Amambua-Ngwa; David J Conway; Abdoulaye A Djimdé; Ogobara K Doumbo; Issaka Zongo; Jean-Bosco Ouedraogo; Daniel Alcock; Eleanor Drury; Sarah Auburn; Oliver Koch; Mandy Sanders; Christina Hubbart; Gareth Maslen; Valentin Ruano-Rubio; Dushyanth Jyothi; Alistair Miles; John O'Brien; Chris Gamble; Samuel O Oyola; Julian C Rayner; Chris I Newbold; Matthew Berriman; Chris C A Spencer; Gilean McVean; Nicholas P Day; Nicholas J White; Delia Bethell; Arjen M Dondorp; Christopher V Plowe; Rick M Fairhurst; Dominic P Kwiatkowski Journal: Nat Genet Date: 2013-04-28 Impact factor: 38.330
Authors: Lynn D Blake; Myles E Johnson; Sasha V Siegel; Adonis McQueen; Iredia D Iyamu; Abdul Kadar Shaikh; Michael W Shultis; Roman Manetsch; Dennis E Kyle Journal: Antimicrob Agents Chemother Date: 2017-07-25 Impact factor: 5.191
Authors: Iredia D Iyamu; Yingzhao Zhao; Prakash T Parvatkar; Bracken F Roberts; Debora R Casandra; Lukasz Wojtas; Dennis E Kyle; Debopam Chakrabarti; Roman Manetsch Journal: Bioorg Med Chem Date: 2022-01-14 Impact factor: 3.461
Authors: Raghupathi Neelarapu; Jordany R Maignan; Cynthia L Lichorowic; Andrii Monastyrskyi; Tina S Mutka; Alexis N LaCrue; Lynn D Blake; Debora Casandra; Sherwin Mashkouri; Jeremy N Burrows; Paul A Willis; Dennis E Kyle; Roman Manetsch Journal: J Med Chem Date: 2018-02-09 Impact factor: 7.446
Authors: Dina Coertzen; Janette Reader; Mariëtte van der Watt; Sindisiwe H Nondaba; Liezl Gibhard; Lubbe Wiesner; Peter Smith; Sarah D'Alessandro; Donatella Taramelli; Ho Ning Wong; Jan L du Preez; Ronald Wai Keung Wu; Lyn-Marie Birkholtz; Richard K Haynes Journal: Antimicrob Agents Chemother Date: 2018-07-27 Impact factor: 5.191
Authors: Andrii Monastyrskyi; Fabian Brockmeyer; Alexis N LaCrue; Yingzhao Zhao; Steven P Maher; Jordany R Maignan; Vivian Padin-Irizarry; Yana I Sakhno; Prakash T Parvatkar; Ami H Asakawa; Lili Huang; Debora Casandra; Sherwin Mashkouri; Dennis E Kyle; Roman Manetsch Journal: J Med Chem Date: 2021-05-12 Impact factor: 8.039
Authors: Jordany R Maignan; Cynthia L Lichorowic; James Giarrusso; Lynn D Blake; Debora Casandra; Tina S Mutka; Alexis N LaCrue; Jeremy N Burrows; Paul A Willis; Dennis E Kyle; Roman Manetsch Journal: J Med Chem Date: 2016-07-12 Impact factor: 8.039